Information om | Engelska ordet AMIKACIN


AMIKACIN

Antal bokstäver

8

Är palindrom

Nej

12
AC
ACI
AM
AMI
CI
CIN
IK

1

1

297
AA
AAC
AAI
AAK
AAM


Sök efter AMIKACIN på:



Exempel på hur man kan använda AMIKACIN i en mening

  • Evidence is insufficient to support its use in other conditions though a retrospective study found it 95% effective in the treatment of Mycobacterium avium complex (MAC) when administered with a macrolide and ethambutol, as well as the drugs amikacin and clarithromycin.
  • Postinfection treatment involves a combination of antituberculosis antibiotics, including rifampicin, rifabutin, ciprofloxacin, amikacin, ethambutol, streptomycin, clarithromycin or azithromycin.
  • The type strain is susceptible in vitro to imipenem, minocycline, doxycycline, clarithromycin, erythromycin, azithromycin, amikacin, ciprofloxacin, ofloxacin, sparfloxacin, and amoxicillinclavulanate and resistant to penicillin, amoxicillin, and vancomycin.
  • The type strain isolates were susceptible in vitro to ciprofloxacin, amikacin, tobramycin, cefoxitin, clarithromycin, doxycycline, sulfamethoxazole and imipenem.
  • They are susceptible to the antibiotics amikacin, ethambutol, and sulfamethoxazole but show intermediate susceptibility to ciprofloxacin, doxycycline and tobramycin and variable susceptibility to cefmetazole, cefoxitin and clarithromycin.
  • Isolates have been shown to be resistant to the antibiotics amikacin and rifampin and partially resistant to ciprofloxacin, cycloserine, ethambutol, isoniazid, rifabutin and streptomycin.
  • The proposed empirical treatment approach includes antibiotics such as amikacin, clarithromycin, or rifabutin, taking into consideration reported resistance to doxycycline and minocycline.
  • The type strain is susceptible to amikacin and sulfamethoxazole, intermediately susceptible to doxycycline and ciprofloxacin, variably susceptible to cefmetazole, cefoxitin, chloramphenicol and clarithromycin, and resistant to isoniazid, rifampin and tobramycin.
  • The World Health Organization (WHO) defines XDR-TB as MDR-TB that is resistant to at least one fluoroquinolone and a second-line injectable drug (amikacin, capreomycin, or kanamycin).
  • MDR-TB can become resistant to the major second-line TB drug groups: fluoroquinolones (moxifloxacin, ofloxacin) and injectable aminoglycoside or polypeptide drugs (amikacin, capreomycin, kanamycin).
  • Out of ten common antibiotic genes that were tested (gatamicin, cefazolin, penicillin, trimethoprim/sulfmethoxazole, ampicillin, carbenicillin, erythromycin, amikacin, chloramphenicol, and norfloxacin), L.
  • Concentration-dependent antibiotics, such as gentamicin and amikacin, are best suited for RLP because they have higher efficacy at higher concentrations, while time-dependent antibiotics such as penicillin and ceftiofur may be used, but have a shorter duration.
  • Ticarcillin (often used in combination with clavulanic acid under the designation Timentin), amikacin sulfate, penicillin, and gentamicin are commonly used.
  • Extensively drug resistant tuberculosis is tuberculosis that is resistant to isoniazid and rifampicin, any fluoroquinolone, and any of the three second line injectable TB drugs (amikacin, capreomycin, and kanamycin).
  • Sphingobacterium olei is resistant to antibiotics including chloromycetin, kanamycin, polymyxin B, streptomycin, amikacin, gentamicin, lincomycin, novobiocin and neomycin.
  • Access group antibiotics include amikacin, amoxicillin, amoxicillin/clavulanic acid, ampicillin, benzylpenicillin, cefalexin, chloramphenicol, clindamycin, doxycycline, Metronidazole and nitrofurantoin.


Förberedelsen av sidan tog: 96,07 ms.